Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REZAFUNGIN vs RIBAVIRIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REZAFUNGIN vs RIBAVIRIN: Safety Overview

Metric REZAFUNGIN RIBAVIRIN
Total FAERS Reports 108 43,397
Deaths Reported 12 2,494
Death Rate 11.1% 5.7%
Hospitalizations 20 8,495
Average Patient Age 53.8 yrs 55.7 yrs
% Female Patients 54.3% 44.3%
FDA Approval Date Mar 22, 2023 Apr 18, 2008
Manufacturer Melinta Therapeutics, LLC Aurobindo Pharma Limited
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued